Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Junji Fujikura"'
Autor:
Ryota Nakagawa, Sachiko Minamiguchi, Tatsuki R. Kataoka, Junji Fujikura, Toshihiko Masui, Masakazu Fujimoto, Yosuke Yamada, Yasuhide Takeuchi, Yuki Teramoto, Hiroaki Ito, Manduwa Saka, Kyohei Kitamura, Shinya Otsuki, Ryohei Nishijima, Hironori Haga
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-7 (2023)
Abstract Background Adult non-neoplastic hyperinsulinemic hypoglycemia (ANHH), also known as adult-onset nesidioblastosis, is a rare cause of endogenous hyperinsulinemic hypoglycemia in adults. This disease is characterized by diffuse hyperplasia of
Externí odkaz:
https://doaj.org/article/e631fd30be5b443d81aa2de76a7fb4ae
Autor:
Takaaki Murakami, Toshihiro Nakamura, Hiroyuki Fujimoto, Junji Fujikura, Yoichi Shimizu, Kanae K. Miyake, Daisuke Otani, Kentaro Sakaki, Sakura Kiyobayashi, Takayuki Anazawa, Yuji Nakamoto, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 10, Pp 1187-1191 (2023)
ABSTRACT It is crucial to develop practical and noninvasive methods to assess the functional beta‐cell mass in a donor pancreas, in which monitoring and precise evaluation is challenging. A patient with type 1 diabetes underwent noninvasive imaging
Externí odkaz:
https://doaj.org/article/36def31fe724486c943ffe2dd1442a7b
Autor:
Ryo Ito, Azuma Kimura, Yurie Hirose, Yu Hatano, Atsushi Mima, Shin-Ichi Mae, Yamato Keidai, Toshihiro Nakamura, Junji Fujikura, Yohei Nishi, Akira Ohta, Taro Toyoda, Nobuya Inagaki, Kenji Osafune
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract For pluripotent stem cell (PSC)-based regenerative therapy against diabetes, the differentiation efficiency to pancreatic lineage cells needs to be improved based on the mechanistic understanding of pancreatic differentiation. Here, we aimed
Externí odkaz:
https://doaj.org/article/df2cb19d80214e9ca8bdf82af4846cfd
Autor:
Yamato Keidai, Junji Fujikura, Toshihiro Nakamura, Takayuki Anazawa, Ryo Ito, Masahito Ogura, Etsuro Hatano, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 11, Pp 1939-1942 (2022)
ABSTRACT Insulin antibodies (IAs) can cause glycemic variability. Islet transplantation (ITx) is a treatment for insulin‐deficient diabetes that aims to establish on‐target glycemic control in the absence of hypoglycemia. To date, there has not b
Externí odkaz:
https://doaj.org/article/f058a7404cf84531910e6036946f557c
Autor:
Takaaki Murakami, Hiroyuki Fujimoto, Keita Hamamatsu, Yuki Yamauchi, Yuzo Kodama, Naotaka Fujita, Junji Fujikura, Yoichi Shimizu, Yuji Nakamoto, Hiroyuki Kimura, Hideo Saji, Nobuya Inagaki
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET),
Externí odkaz:
https://doaj.org/article/eb79b0bd544f428e86385fa7f2a8e030
Autor:
Toshihiro Nakamura, Junji Fujikura, Takayuki Anazawa, Ryo Ito, Masahito Ogura, Hideaki Okajima, Hirofumi Noguchi, Shinji Uemoto, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1677-1680 (2020)
Abstract To date, studies of patients with islet transplantation addressing intermittently scanned continuous glucose monitoring profile and the flexibility of the graft islet function under different doses of insulin administration, both of which re
Externí odkaz:
https://doaj.org/article/3945f8c6b19b40d19aa8eff25393e706
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 143-145 (2021)
Externí odkaz:
https://doaj.org/article/e3a0600979bc4e1abb36bcf992caf97e
Autor:
Toshihiro Nakamura, Junji Fujikura, Takayuki Anazawa, Ryo Ito, Masahito Ogura, Hideaki Okajima, Shinji Uemoto, Nobuya Inagaki
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 363-372 (2020)
Abstract Aims/Introduction To investigate the long‐term efficacy and safety of islet transplantation (ITx) compared with multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). Materials and Methods Among 619 patients di
Externí odkaz:
https://doaj.org/article/4b8267749cc949eaa2d6d4d131fa240f
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47536 (2012)
Tubular complexes (TCs) are aggregates of duct-like monolayered cells in the developing and regenerating pancreas. Recent studies showed that TCs have regenerative potential, including islet neogenesis. We previously delivered adenovirus vector (AdV)
Externí odkaz:
https://doaj.org/article/dfe2780485d848b5a85fe2d6fba643e6
Autor:
Wataru Ogawa, Nobuya Inagaki, Michio Shimabukuro, K Ueki, Nobuhiro Shojima, Motoyoshi Tsujino, Junji Fujikura, Hiroaki Masuzaki, Eri Kikkawa, Koutaro Yokote, Satoshi Ugi, Hitoshi Nishizawa, Atsuhito Saiki, Takehiro Nozaki, Hiroaki Watada, Karin Hayashi, Yushi Hirota, Iichiro Shimomura, Yasushi Ishigaki, Akira Sasaki, Hidenori Koyama, Ichiro Tatsuno, Yosuke Seki, Takashi Kadowaki, Takeshi Naitoh, Masayuki Ohta, Toshimasa Yamauchi, Takashi Yamaguchi, Shinichi Okazumi, Kazunori Kasama, Takeshi Miyatsuka
Publikováno v:
Diabetology international
Bariatric surgery has been shown to have a variety of metabolically beneficial effects for patients with type 2 diabetes (T2D), and is now also called metabolic surgery. At the 2nd Diabetes Surgery Summit held in 2015 in London, the indication for ba